BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

643 related articles for article (PubMed ID: 27086005)

  • 21. Fatty liver disease and obesity in youth.
    Della Corte C; Mazzotta AR; Nobili V
    Curr Opin Endocrinol Diabetes Obes; 2016 Feb; 23(1):66-71. PubMed ID: 26702852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The diagnosis and treatment of non-alcoholic fatty liver disease.
    Altinbas A; Sowa JP; Hasenberg T; Canbay A
    Minerva Gastroenterol Dietol; 2015 Sep; 61(3):159-69. PubMed ID: 26080905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Omega-3 fatty acids: Mechanisms of benefit and therapeutic effects in pediatric and adult NAFLD.
    Nobili V; Alisi A; Musso G; Scorletti E; Calder PC; Byrne CD
    Crit Rev Clin Lab Sci; 2016; 53(2):106-20. PubMed ID: 26463349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-alcoholic fatty liver disease: A poorly known pandemic.
    Augustin S; Graupera I; Caballeria J;
    Med Clin (Barc); 2017 Dec; 149(12):542-548. PubMed ID: 28751080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel Strategies to Treat Hepatic Steatosis and Steatohepatitis.
    Perry RJ
    Obesity (Silver Spring); 2019 Sep; 27(9):1385-1387. PubMed ID: 31343116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonalcoholic Fatty Liver Disease in Children: Hepatic and Extrahepatic Complications.
    Selvakumar PKC; Kabbany MN; Nobili V; Alkhouri N
    Pediatr Clin North Am; 2017 Jun; 64(3):659-675. PubMed ID: 28502444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Research advances in pediatric nonalcoholic fatty liver disease].
    Dai DL
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Jan; 17(1):107-12. PubMed ID: 25616307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systems biology approaches for studying the pathogenesis of non-alcoholic fatty liver disease.
    Fisher CP; Kierzek AM; Plant NJ; Moore JB
    World J Gastroenterol; 2014 Nov; 20(41):15070-8. PubMed ID: 25386055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pediatric non-alcoholic fatty liver disease: an increasing public health issue.
    Berardis S; Sokal E
    Eur J Pediatr; 2014 Feb; 173(2):131-9. PubMed ID: 24068459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease.
    Pacifico L; Bonci E; Marandola L; Romaggioli S; Bascetta S; Chiesa C
    World J Gastroenterol; 2014 Dec; 20(45):17107-14. PubMed ID: 25493023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Non-alcoholic fatty liver disease and hepatocellular carcinoma - 2016].
    Pár A; Pár G
    Orv Hetil; 2016 Jun; 157(25):987-94. PubMed ID: 27287838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence.
    Temple JL; Cordero P; Li J; Nguyen V; Oben JA
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27314342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-Alcoholic Fatty Liver Disease in Patients with HIV Infection.
    Papagianni M; Tziomalos K
    AIDS Rev; 2018; 20(3):171-173. PubMed ID: 30264828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis.
    Diehl AM; Day C
    N Engl J Med; 2017 Nov; 377(21):2063-2072. PubMed ID: 29166236
    [No Abstract]   [Full Text] [Related]  

  • 35. Effectiveness of a carbohydrate restricted diet to treat non-alcoholic fatty liver disease in adolescents with obesity: Trial design and methodology.
    Dowla S; Pendergrass M; Bolding M; Gower B; Fontaine K; Ashraf A; Soleymani T; Morrison S; Goss A
    Contemp Clin Trials; 2018 May; 68():95-101. PubMed ID: 29601997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum vascular endothelial cadherin and thrombomodulin are markers of non-alcoholic fatty liver disease in children.
    Kan X; Liu G; Yang Y; Yang Q; Li Y; Wang F
    J Pediatr Endocrinol Metab; 2016 Dec; 29(12):1331-1335. PubMed ID: 26959535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pediatric Non-Alcoholic Fatty Liver Disease: Nutritional Origins and Potential Molecular Mechanisms.
    Mandala A; Janssen RC; Palle S; Short KR; Friedman JE
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33081177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Albanian overweight children.
    Kodhelaj K; Resuli B; Petrela E; Malaj V; Jaze H
    Minerva Pediatr; 2014 Feb; 66(1):23-30. PubMed ID: 24608579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obese children with fatty liver: Between reality and disease mongering.
    Ranucci G; Spagnuolo MI; Iorio R
    World J Gastroenterol; 2017 Dec; 23(47):8277-8282. PubMed ID: 29307987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonalcoholic fatty liver disease - current status and future directions.
    Demir M; Lang S; Steffen HM
    J Dig Dis; 2015 Oct; 16(10):541-57. PubMed ID: 26406351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.